Hansch L, Peipp M, Mastall M, Villars D, et al. Chimeric antigen receptor (CAR) T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma. Neuro Oncol 2023 Jun 19:noad108. doi: 10.1093.
PMID: 37335916